BioVie Inc. (BIVI) vs Dare Bioscience, Inc. (DARE)

BioVie Inc. and Dare Bioscience, Inc. are both Biotechnology companies. BioVie Inc. and Dare Bioscience, Inc. are of similar size ($14.5M and $13.8M). BioVie Inc. has the higher net margin (0.00% vs −804.3%) and the lower return on invested capital (−1,095.0% vs 0.00%). Across the 12 metrics below, BioVie Inc. leads on 6 and Dare Bioscience, Inc. on 6.

Valuation

Metric BIVI DARE Biotechnology median
P/E n/m n/m 7.88
P/S n/m 8.50 11.47
P/B 1.14 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.07 0.74
EV/Sales n/m (0.47) 10.73
Earnings yield (195.65%) (89.74%) (28.84%)
Free cash flow yield (163.08%) (99.90%) (23.03%)

Profitability

Metric BIVI DARE Biotechnology median
Gross margin 0.00% 58.84% 65.16%
Operating margin 0.00% (813.35%) 0.00%
Net margin 0.00% (804.33%) 0.00%
Free cash flow margin 0.00% (849.36%) 0.00%
Return on equity (151.06%) 165.29% (57.72%)
Return on assets (123.51%) (62.16%) (49.22%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI DARE Biotechnology median
Revenue growth (TTM) — 7,817.51% 5.64%
EPS growth (last fiscal year) 74.83% (150.00%) —
Revenue growth, 5-year CAGR — 66.71% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI DARE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 0.99 4.73
Net debt to EBITDA 0.40 2.07 0.96

Dividend

Metric BIVI DARE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BIVI DARE Biotechnology median
Market cap 13.82m 14.50m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack